
Global Kinetics Corporation delivers continuous, objective monitoring of movement symptoms to support clinical decisions for people with neurological disorders. It does this via the PKG® system: a wrist-worn wearable paired with AI-powered algorithms that record, analyze, and report bradykinesia, dyskinesia, tremor, and immobility for clinicians and researchers. The solution is a healthcare technology product used in clinics and clinical trials and integrates into care pathways for Parkinson’s disease management. The PKG® system is clinically validated and holds regulatory clearances (FDA 510(k), CE mark, TGA), and the company works with hospitals, clinics, and life sciences partners to measure treatment effects and guide therapy.

Global Kinetics Corporation delivers continuous, objective monitoring of movement symptoms to support clinical decisions for people with neurological disorders. It does this via the PKG® system: a wrist-worn wearable paired with AI-powered algorithms that record, analyze, and report bradykinesia, dyskinesia, tremor, and immobility for clinicians and researchers. The solution is a healthcare technology product used in clinics and clinical trials and integrates into care pathways for Parkinson’s disease management. The PKG® system is clinically validated and holds regulatory clearances (FDA 510(k), CE mark, TGA), and the company works with hospitals, clinics, and life sciences partners to measure treatment effects and guide therapy.